1|402|Public
50|$|The association's 11 councils {{serve as}} policy <b>recommending</b> <b>agencies.</b> Each council is {{assigned}} to study issues relating to its special area of interest and to make recommendations on those matters to the Board of Trustees and the House of Delegates.|$|E
50|$|The Orthodox Rabbinical Council of British Columbia is a <b>recommended</b> Kosher <b>Agency</b> by the Chicago Rabbinical Council (CRC).|$|R
25|$|Travel <b>agencies</b> <b>recommends</b> 3 days {{to enjoy}} the town fully.|$|R
5000|$|... § 71103 - Developing {{policy and}} <b>recommending</b> {{responsible}} Federal <b>agency</b> ...|$|R
5000|$|US {{government}} <b>agencies</b> <b>recommend</b> that caregivers {{take the}} following precautions: ...|$|R
2500|$|In an interview, Mayor Kip Holden <b>recommended</b> police <b>agencies</b> {{across the}} U.S. {{to put their}} {{officers}} on high alert and urged Americans to be [...] "vocal about their support for law enforcement".|$|R
25|$|European Medicines <b>Agency</b> <b>recommended</b> {{suspension}} of marketing authorisations for meprobamate-containing medicines in the European Union in January 2012.|$|R
25|$|Development of CIMS {{was also}} {{indirectly}} {{influenced by a}} major review of New Zealand's emergency services, {{which took place in}} the mid-1990s. This review <b>recommended</b> that <b>agencies</b> should look at working closer together, in order to provide a more integrated service to New Zealand communities.|$|R
50|$|Congress {{considers}} additional proposals every year, some <b>recommended</b> {{by federal}} <b>agencies</b> and many proposed by grassroots conservation and sportsmen’s organizations.|$|R
25|$|On January 21, 2010, the European Medicines <b>Agency</b> <b>recommended</b> {{suspension}} of marketing authorizations for sibutramine {{based on the}} SCOUT study results.|$|R
2500|$|... {{rosiglitazone}} (Avandia): the European Medicines <b>Agency</b> <b>recommended</b> in September 2010 that it {{be suspended}} from the EU market due to elevated cardiovascular risks.|$|R
50|$|In February 2016, the European Medicines <b>Agency</b> <b>recommended</b> to {{withdraw}} fusafungine {{from the market}} due to rare but severe allergic reactions (mainly bronchospasms).|$|R
5000|$|... {{rosiglitazone}} (Avandia): the European Medicines <b>Agency</b> <b>recommended</b> in September 2010 that it {{be suspended}} from the EU market due to elevated cardiovascular risks.|$|R
50|$|In the United States, {{both the}} American Academy of Pediatrics and the United States Environmental Protection <b>Agency</b> <b>recommend</b> that {{alternative}} thermometers {{be used in}} the home.|$|R
50|$|Certain tour books, such as Lonely Planet, cover Burma, {{stating that}} it {{provides}} balanced information and spending methods {{to get the money}} {{into the hands of the}} people, while some, such as Rough Guides, refuse to publish on Burma. Most Ministries of Foreign Affairs in the Western world <b>recommend</b> travel <b>agencies</b> and citizens not to engage in tourism activities in Burma.|$|R
50|$|In November 2015, Savinova {{was one of}} five Russian runners the World Anti-Doping <b>Agency</b> <b>recommended</b> {{to receive}} a {{lifetime}} ban for doping during the London Olympics, along with Ekaterina Poistogova.|$|R
50|$|In November 2015, {{after an}} investigation, Poistogova {{was one of}} five Russian runners whom the World Anti-Doping <b>Agency</b> <b>recommended</b> to receive a {{lifetime}} ban for doping during the London Olympics.|$|R
5000|$|In 2011, the <b>agency</b> <b>recommended</b> {{the removal}} from office of {{district}} court judge Tor Holger Bertelsen. (No district court judge {{has been removed from}} office in Norway, after World War Two.) ...|$|R
50|$|Bufexamac {{can cause}} severe contact {{dermatitis}} {{which is often}} hard to distinguish from the initial condition. As a consequence, the European Medicines <b>Agency</b> <b>recommended</b> to withdraw the marketing approval in April 2010.|$|R
50|$|The European Medicines <b>Agency</b> <b>recommended</b> the {{granting}} of a marketing authorisation for reslizumab (EU trade name Cinqaero) intended as add-on treatment in adult patients with severe eosinophilic asthma on 23 June 2016.|$|R
50|$|Health <b>agencies</b> <b>recommend</b> {{that people}} {{maintain}} a normal weight by limiting consumption of energy-dense foods and sugary drinks, eating plant-based food, limiting consumption {{of red and}} processed meat, and limiting alcohol intake.|$|R
50|$|Good {{manufacturing}} practices (GMP) are {{the practices}} required {{in order to}} conform to the guidelines <b>recommended</b> by <b>agencies</b> that control authorization and licensing for manufacture and sale of food, drug products, and active pharmaceutical products. These guidelines provide minimum requirements that a pharmaceutical or a food product manufacturer must meet to assure that the products are of high quality and do not pose any risk to the consumer or public.|$|R
40|$|This paper {{analyzes}} {{traffic accidents}} in work zones in South Carolina from 1997 - 2001 and offers recommendations. It is <b>recommend</b> the <b>agency</b> continue applying for federal work zone grants to fund various work zone actives. The agency {{should continue to}} train employees and educate the public through television commercials, radio ads and billboards advertisements, statewide school education briefings and mandatory workplace training for {{the private and public}} sector...|$|R
50|$|In early , Russia's Federal Air Transport <b>Agency</b> <b>recommended</b> {{that the}} airline's {{certificate}} should be revoked. The revocation was announced on 31 December 2013, and the aircraft {{part of the}} company was transferred to Ak Bars Aero.|$|R
5000|$|On March 9, 1999 the {{agencies}} released the framework titled the Unified National Strategy for Animal Feeding Operations. In the framework, the <b>agencies</b> <b>recommended</b> six major activities {{to be included}} in operations’ Comprehensive Nutrient Management Plans (CNMPs): ...|$|R
50|$|The {{commission}} may <b>recommend</b> that an <b>agency</b> {{be continued}} {{in its present}} form (nearly always with recommendations to the legislature for improvement), consolidated with another agency, or abolished, with its duties either eliminated or transferred to other agencies.|$|R
50|$|In 2014, the European Medicines <b>Agency</b> <b>recommended</b> {{approval}} of Holoclar, a treatment involving stem cells, {{for use in}} the European Union. Holoclar is used for people with severe limbal stem cell deficiency due to burns in the eye.|$|R
25|$|The UK Food Standards <b>Agency</b> <b>recommends</b> that {{at least}} two {{portions}} of seafood should be consumed each week, one of which should be oil-rich. There are over 100 different types of seafood available around the coast of the UK.|$|R
25|$|Because {{they contain}} mercury, many {{fluorescent}} lamps {{are classified as}} hazardous waste. The United States Environmental Protection <b>Agency</b> <b>recommends</b> that fluorescent lamps be segregated from general waste for recycling or safe disposal, and some jurisdictions require recycling of them.|$|R
50|$|The UK Food Standards <b>Agency</b> <b>recommends</b> that {{at least}} two {{portions}} of seafood should be consumed each week, one of which should be oil-rich. There are over 100 different types of seafood available around the coast of the UK.|$|R
5000|$|Nivolumab {{received}} FDA {{approval for}} the treatment of melanoma in December 2014. [...] In April 2015, the Committee for Medicinal Products for Human Use of the European Medicines <b>Agency</b> <b>recommended</b> approval of Nivolumab for metastatic melanoma as a monotherapy.|$|R
50|$|In late October 2015, the United States Environmental Protection <b>Agency</b> <b>recommended</b> to Federal Energy Regulatory Commission {{that the}} {{pipeline}} be rerouted {{away from the}} Floridan aquifer because of the karst geology that is prone to sinkholes and also contains wetlands.|$|R
50|$|The Commission also {{performs}} limited reviews on agencies {{not subject}} to sunset {{at the discretion of}} the Legislature, and can <b>recommend</b> that the <b>agency</b> be abolished; however, in those cases the Legislature must pass specific action to abolish the agency.|$|R
50|$|In July 2017 an FDA {{advisory}} committee unanimously <b>recommended</b> that the <b>agency</b> approve it to treat B cell acute lymphoblastic leukemia patients {{who did not}} respond adequately to other treatments or have relapsed. The FDA {{may or may not}} follow this recommendation.|$|R
50|$|On October 3, 2007, Health Canada {{requested}} {{sales of}} Prexige to stop. Novartis {{has agreed to}} the request and has taken steps to do so. On December 13, 2007, the European Medicines <b>Agency</b> <b>recommended</b> the withdrawal for Prexige from all EU markets.|$|R
25|$|Due {{to reports}} of adverse {{withdrawal}} reactions upon terminating treatment, the Committee for Medicinal Products for Human Use (CHMP) at the European Medicines <b>Agency</b> <b>recommends</b> gradually reducing over several {{weeks or months}} if the decision to withdraw is made. See also Discontinuation syndrome (withdrawal).|$|R
